Physician

Sherwin Farzad Attai, MD

According to 2025 Medicare claims, Sherwin Attai, MD (NPI: 1861540726) practices interventional cardiology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is WACO CARDIOLOGY ASSOCIATES (NPI: 1982607735; TIN: 74-1784088) and primary practice location at 76712-4054. Attai is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Attai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,397 traditional Medicare patients, billed 9,043 HCPCS/CPT codes, and received $830,245 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 10,051 prescription claims across 1,198 beneficiaries totaling $1,411,035 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 44 claims. Open Payments data shows 2 records totaling $54. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $331,610 to $1,411,035. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	4,381	22,038	$833,185
2016	4,619	17,828	$737,613
2017	4,109	15,179	$630,031
2018	3,405	15,399	$581,383
2019	3,130	8,623	$536,599
2020	2,403	8,482	$511,845
2021	2,304	6,089	$443,974
2022	2,390	5,959	$518,724
2023	2,240	8,447	$560,197
2024	2,397	9,043	$830,245

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	872	7,482	$331,610
2016	1,029	9,518	$509,430
2017	973	9,297	$506,339
2018	921	8,141	$494,608
2019	994	7,813	$655,673
2020	1,018	8,424	$903,854
2021	1,073	8,611	$1,088,422
2022	1,132	8,984	$1,303,681
2023	1,131	9,526	$1,443,517
2024	1,198	10,051	$1,411,035

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	44	$2,698
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	589	694	$85
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	261	263	$74
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	533	824	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	534	821	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	447	480	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	885	36,300	$676,397
Xarelto	Rivaroxaban	256	13,774	$244,232
Repatha Sureclick	Evolocumab	237	8,826	$166,005
Entresto	Sacubitril/Valsartan	87	2,840	$58,273
Vascepa	Icosapent Ethyl	78	3,720	$37,627

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$54	Actelion Pharmaceuticals US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sherwin Farzad Attai, MD?

Tedicare shows public-source Medicare data for Sherwin Farzad Attai, MD (NPI 1861540726), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sherwin Farzad Attai, MD have ACO affiliation data?

Sherwin Farzad Attai, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Sherwin Farzad Attai, MD?

Sherwin Farzad Attai, MD is linked to WACO CARDIOLOGY ASSOCIATES (billing NPI 1982607735) in the available physician profile data.

Does Sherwin Farzad Attai, MD have Open Payments data?

Sherwin Farzad Attai, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.